Each capsule delivers 500 mcg of BPC-157 in a convenient once-daily oral capsule, making it easy to incorporate into a daily wellness routine.*
Insert the needle at the angle you were taught (90 degrees for a perpendicular injection or 45 degrees for an angled injection)
Preclinical colitis models: KPV reduces mucosal inflammation in preclinical colitis models, with demonstrated reductions in TNF-, IL-6, and other pro-inflammatory markers
Full results typically build over 46 weeks
Approval is a separate pathway entirely, in which a sponsor submits clinical evidence for a specific finished product and FDA determines it is safe and effective for a specific use
Shipping fees, if any, are clearly displayed before payment confirmation